{"id":47799,"date":"2019-11-05T13:55:43","date_gmt":"2019-11-05T11:55:43","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=47799"},"modified":"2019-11-05T13:55:43","modified_gmt":"2019-11-05T11:55:43","slug":"atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/","title":{"rendered":"Atenci\u00f3n farmac\u00e9utica en el ojo seco: ampliar conocimientos para ofrecer soluciones eficaces a los pacientes"},"content":{"rendered":"<p>El pasado 24 de octubre tuvo lugar en el Colegio la <strong>conferencia \u201cActuaci\u00f3n farmac\u00e9utica en el ojo seco\u201d<\/strong> a cargo de Jos\u00e9 Lamarca, oftalm\u00f3logo especialista en cirug\u00eda refractiva, <em>Deputy Director <\/em>del Instituto Barraquer y profesor en la Universidad Internacional de Catalunya (UIC). La encargada de moderar la sesi\u00f3n fue <strong>Aina Surroca<\/strong>, vocal del COFB, responsable de la Comisi\u00f3n Delegada de Formaci\u00f3n Continua.<\/p>\n<p>Durante la<strong> conferencia<\/strong>, se profundiz\u00f3 en los <strong>diferentes tipos de ojo seco<\/strong>, su <strong>sintomatolog\u00eda<\/strong>, las diferentes opciones de <strong>l\u00e1grimas artificiales<\/strong> y en cu\u00e1les son las <strong>diferencias con otros<\/strong> <strong>patolog\u00edas oculares<\/strong>. El<strong>ojo seco<\/strong>, aunque se asocia muchas veces a la falta de hidrataci\u00f3n, es una <strong>enfermedad multifactorial con<\/strong> <strong>diferentes sintomatolog\u00edas y tratamientos<\/strong>. Es importante conocer la <strong>sequedad ocular<\/strong> para poder ofrecer una <strong>soluci\u00f3n eficaz<\/strong> que mejore la <strong>calidad de vida<\/strong> <strong>de los pacientes<\/strong>.<\/p>\n<figure id=\"attachment_47922\" aria-describedby=\"caption-attachment-47922\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/11\/cofb.191024-10.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-47922 size-large\" title=\"El dr. Jos\u00e9 Lamarca en un momento del curso &quot;Actuaci\u00f3n farmac\u00e9utica en el ojo seco&quot;.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/11\/cofb.191024-10-1024x683.jpg\" alt=\"El Dr. Jos\u00e9 Lamarca en un moment del curs &quot;Actuaci\u00f3 farmac\u00e8utica en l'ull sec&quot;.\" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-47922\" class=\"wp-caption-text\">El dr. Jos\u00e9 Lamarca en un momento del curso &quot;Actuaci\u00f3n farmac\u00e9utica en el ojo seco&quot;.<\/figcaption><\/figure>\n<h1><span style=\"color: #008080;\"><strong>Causas del ojo seco<\/strong><\/span><\/h1>\n<p>Seg\u00fan el dr. Lamarca, el ojo seco puede resultar de cualquier enfermedad y se asocia a la <strong>deficiencia de los componentes de las capas de la l\u00e1grima<\/strong>, anormalidades en la <strong>p\u00e1rpado<\/strong> o anormalidades <strong>epiteliales<\/strong>. Entre las <strong>posibles causas<\/strong> encontramos: las condiciones propias del individuo o fisiopatol\u00f3gicas; los factores externos o ambientales y los factores m\u00e9dico-farmacol\u00f3gicos.<\/p>\n<p>En cuanto a las <strong>condiciones propias del individuo<\/strong> que pueden <strong>causar el ojo seco<\/strong> encontramos bajo ratio de parpadeo, mayor apertura del p\u00e1rpado, cambios hormonales (niveles altos de estr\u00f3genos, menopausia, etc.), edad, d\u00e9ficits de \u00e1cidos grasos esenciales (Omega-3) y determinadas enfermedades (artritis reumatoide, lupus, etc.) .). En relaci\u00f3n con los <strong>factores externos o ambientales<\/strong>,<strong>\u00a0<\/strong>cabe destacar el tabaco, los ambientes secos (exterior o interior con calefacciones o aires acondicionados) y el uso de ordenadores, televisi\u00f3n, etc. durante largos per\u00edodos. Por \u00faltimo, los <strong>factores m\u00e9dico-farmacol\u00f3gicos<\/strong> que pueden causarlo son las lentillas, las cirug\u00edas oculares o algunos medicamentos, tanto t\u00f3picos como sist\u00e9micos.<\/p>\n<p>Tambi\u00e9n hay ciertos medicamentos que pueden causarlo como el uso de <strong>f\u00e1rmacos con actividad anticolin\u00e9rgica<\/strong> (antidepresivos, antihistam\u00ednicos, descongestionantes nasales, antitus\u00edgenos\u2026); el uso de f\u00e1rmacos con actividad betabloqueante (antihipertensivos y colirios antigualucomatosos), el uso de f\u00e1rmacos con efecto anest\u00e9sico o el uso de f\u00e1rmacos que alteran la gl\u00e1ndula lagrimal as\u00ed como algunos tratamientos de quimioterapia o radioterapia.<\/p>\n<figure id=\"attachment_47923\" aria-describedby=\"caption-attachment-47923\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/11\/cofb.191024-23.jpg\"><img decoding=\"async\" class=\"wp-image-47923 size-large\" title=\"Aina Surroca, vocal del COFB, responsable de la Comisi\u00f3n delegada de formaci\u00f3n continua, fue la encargada de moderar la sesi\u00f3n. \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/11\/cofb.191024-23-1024x683.jpg\" alt=\"Aina Surroca, vocal del COFB, responsable de la Comissi\u00f3 delegada de formaci\u00f3 continuada, va ser l'encarregada de moderar la sessi\u00f3. \" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-47923\" class=\"wp-caption-text\">Aina Surroca, vocal del COFB, responsable de la Comisi\u00f3n delegada de formaci\u00f3n continua, fue la encargada de moderar la sesi\u00f3n.<\/figcaption><\/figure>\n<h1><span style=\"color: #008080;\"><strong>S\u00edntomas y situaciones que requieren derivaci\u00f3n al oftalm\u00f3logo<\/strong><\/span><\/h1>\n<p>Algunos de los <strong>s\u00edntomas del ojo seco<\/strong> que destac\u00f3 el doctor son la sensaci\u00f3n de <strong>cuerpo extra\u00f1o<\/strong>, de<strong>irritaci\u00f3n<\/strong>, <strong>ardor<\/strong>, <strong>picor<\/strong>, <strong>intolerancia a las lentillas.<\/strong>\u00a0Tambi\u00e9n hizo referencia a las sensaciones poco confortables despu\u00e9s de dormir, leer o visualizar una pantalla de forma prolongada.<\/p>\n<p>Lamarca apunt\u00f3 algunas de las <strong>situaciones que requieren que los farmac\u00e9uticos deriven a los pacientes al oftalm\u00f3logo<\/strong> como pacientes menores de 12 a\u00f1os, pacientes con alguna patolog\u00eda ocular cr\u00f3nica, encontrarse ante la sospecha de la existencia de otras patolog\u00edas oculares, presencia de un dolor ocular intenso, que los s\u00edntomas no remitan o mejoren despu\u00e9s de 3-4 d\u00edas de tratamiento, casos de p\u00e9rdida y\/o alteraci\u00f3n de la visi\u00f3n o presencia de un cuerpo extra\u00f1o que no desaparezca despu\u00e9s de un ba\u00f1o ocular o que siga provocando molestias y\/o dolor despu\u00e9s de desaparecer.<\/p>\n<h1><strong><span style=\"color: #008080;\">\u00bfC\u00f3mo diferenciar el ojo seco de otras patolog\u00edas desde el mostrador?<\/span><\/strong><\/h1>\n<p>Otra de las <strong>cuestiones abordadas<\/strong> por el doctor fue <strong>c\u00f3mo diferenciar el ojo seco<\/strong> <strong>otras patolog\u00edas<\/strong> como la conjuntivitis, la queratitis, la blefaritis, los b\u00fahos, el calazi o la alergia. En el caso de la alergia expuso que la principal diferencia con la sequedad ocular es la inflamaci\u00f3n del p\u00e1rpado y la presencia de otros s\u00edntomas asociados como picor, congesti\u00f3n nasal, estornudos, etc. Por \u00faltimo, la \u00faltima parte de la sesi\u00f3n se dedic\u00f3 a la resoluci\u00f3n de casos pr\u00e1cticos y de las dudas de los asistentes.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\"><strong>Con el patrocinio de:<\/strong><\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/www.brillpharma.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignright wp-image-47801\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/10\/Brill-Pharma.jpg\" alt=\"\" width=\"170\" height=\"59\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Otras publicaciones de inter\u00e9s:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/blog.cofb.cat\/patologies-oftalmologiques-de-mes-prevalenca-i-altres-alteracions-oculars\/\" target=\"_blank\" rel=\"noopener\">Patolog\u00edas oftalmol\u00f3gicas de mayor prevalencia y otras alteraciones oculares (Abril 2018)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\" target=\"_blank\" rel=\"noopener\">Formaciones COFB: \u00bfcu\u00e1les son las patolog\u00edas oftalmol\u00f3gicas de mayor prevalencia? (Mayo 2017)<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>El pasado 24 de octubre tuvo lugar en el Colegio la conferencia \u201cActuaci\u00f3n farmac\u00e9utica en el ojo seco\u201d a cargo de Jos\u00e9 Lamarca, oftalm\u00f3logo especialista en cirug\u00eda refractiva, Deputy Director del Instituto Barraquer y profesor en la Universidad Internacional de Catalu\u00f1a (UIC). La encargada de moderar la sesi\u00f3n fue Aina Surroca, vocal [\u2026]<\/p>","protected":false},"author":1,"featured_media":47922,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[18,19,520,53,68,69,70,45,2770,3705,2771,3284,3660,3706,63,3707,3708],"class_list":["post-47799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-conferencia","tag-farmaceutics","tag-farmacia","tag-farmacia-comunitaria","tag-formacio","tag-medicaments","tag-oftalmologia","tag-patologies-oculars","tag-patologies-oftalmologiques","tag-programa-formatiu","tag-programa-formatiu-2019-2020","tag-sequedat-ocular","tag-tractament","tag-ull","tag-ull-sec"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Atenci\u00f3 farmac\u00e8utica en l&#039;ull sec: ampliar coneixements per oferir solucions eficaces als pacients - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 24 d&#039;octubre va tenir lloc al Col\u00b7legi la confer\u00e8ncia &quot;Actuaci\u00f3 farmac\u00e8utica en l&#039;ull sec&quot; a c\u00e0rrec de Jos\u00e9 Lamarca, oftalm\u00f2leg especialista en cirurgia refractiva, Deputy Director de l&#039;Institut Barraquer i professor a la Universitat Internacional de Catalunya (UIC).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atenci\u00f3 farmac\u00e8utica en l&#039;ull sec: ampliar coneixements per oferir solucions eficaces als pacients - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 24 d&#039;octubre va tenir lloc al Col\u00b7legi la confer\u00e8ncia &quot;Actuaci\u00f3 farmac\u00e8utica en l&#039;ull sec&quot; a c\u00e0rrec de Jos\u00e9 Lamarca, oftalm\u00f2leg especialista en cirurgia refractiva, Deputy Director de l&#039;Institut Barraquer i professor a la Universitat Internacional de Catalunya (UIC).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-05T11:55:43+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Atenci\u00f3 farmac\u00e8utica en l&#8217;ull sec: ampliar coneixements per oferir solucions eficaces als pacients\",\"datePublished\":\"2019-11-05T11:55:43+00:00\",\"dateModified\":\"2019-11-05T11:55:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/\"},\"wordCount\":784,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"confer\u00e8ncia\",\"farmac\u00e8utics\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"medicaments\",\"oftalmologia\",\"patologies oculars\",\"patologies oftalmol\u00f2giques\",\"programa formatiu\",\"programa formatiu 2019-2020\",\"sequedat ocular\",\"tractament\",\"ull\",\"ull sec\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/\",\"name\":\"Atenci\u00f3 farmac\u00e8utica en l'ull sec: ampliar coneixements per oferir solucions eficaces als pacients - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2019-11-05T11:55:43+00:00\",\"dateModified\":\"2019-11-05T11:55:43+00:00\",\"description\":\"El passat 24 d'octubre va tenir lloc al Col\u00b7legi la confer\u00e8ncia \\\"Actuaci\u00f3 farmac\u00e8utica en l'ull sec\\\" a c\u00e0rrec de Jos\u00e9 Lamarca, oftalm\u00f2leg especialista en cirurgia refractiva, Deputy Director de l'Institut Barraquer i professor a la Universitat Internacional de Catalunya (UIC).\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atenci\u00f3 farmac\u00e8utica en l&#8217;ull sec: ampliar coneixements per oferir solucions eficaces als pacients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atenci\u00f3 farmac\u00e8utica en l'ull sec: ampliar coneixements per oferir solucions eficaces als pacients - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 24 d'octubre va tenir lloc al Col\u00b7legi la confer\u00e8ncia \"Actuaci\u00f3 farmac\u00e8utica en l'ull sec\" a c\u00e0rrec de Jos\u00e9 Lamarca, oftalm\u00f2leg especialista en cirurgia refractiva, Deputy Director de l'Institut Barraquer i professor a la Universitat Internacional de Catalunya (UIC).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/","og_locale":"es_ES","og_type":"article","og_title":"Atenci\u00f3 farmac\u00e8utica en l'ull sec: ampliar coneixements per oferir solucions eficaces als pacients - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 24 d'octubre va tenir lloc al Col\u00b7legi la confer\u00e8ncia \"Actuaci\u00f3 farmac\u00e8utica en l'ull sec\" a c\u00e0rrec de Jos\u00e9 Lamarca, oftalm\u00f2leg especialista en cirurgia refractiva, Deputy Director de l'Institut Barraquer i professor a la Universitat Internacional de Catalunya (UIC).","og_url":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2019-11-05T11:55:43+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Atenci\u00f3 farmac\u00e8utica en l&#8217;ull sec: ampliar coneixements per oferir solucions eficaces als pacients","datePublished":"2019-11-05T11:55:43+00:00","dateModified":"2019-11-05T11:55:43+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/"},"wordCount":784,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#primaryimage"},"thumbnailUrl":"","keywords":["COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","confer\u00e8ncia","farmac\u00e8utics","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","medicaments","oftalmologia","patologies oculars","patologies oftalmol\u00f2giques","programa formatiu","programa formatiu 2019-2020","sequedat ocular","tractament","ull","ull sec"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/","url":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/","name":"Atenci\u00f3 farmac\u00e8utica en l'ull sec: ampliar coneixements per oferir solucions eficaces als pacients - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#primaryimage"},"thumbnailUrl":"","datePublished":"2019-11-05T11:55:43+00:00","dateModified":"2019-11-05T11:55:43+00:00","description":"El passat 24 d'octubre va tenir lloc al Col\u00b7legi la confer\u00e8ncia \"Actuaci\u00f3 farmac\u00e8utica en l'ull sec\" a c\u00e0rrec de Jos\u00e9 Lamarca, oftalm\u00f2leg especialista en cirurgia refractiva, Deputy Director de l'Institut Barraquer i professor a la Universitat Internacional de Catalunya (UIC).","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2019\/11\/05\/atencio-farmaceutica-lull-sec-ampliar-coneixements-oferir-solucions-eficaces-als-pacients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Atenci\u00f3 farmac\u00e8utica en l&#8217;ull sec: ampliar coneixements per oferir solucions eficaces als pacients"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 24 d&#8217;octubre va tenir lloc al Col\u00b7legi la confer\u00e8ncia &#8220;Actuaci\u00f3 farmac\u00e8utica en l&#8217;ull sec&#8221; a c\u00e0rrec de Jos\u00e9 Lamarca, oftalm\u00f2leg especialista en cirurgia refractiva, Deputy Director de l&#8217;Institut Barraquer i professor a la Universitat Internacional de Catalunya (UIC). L&#8217;encarregada de moderar la sessi\u00f3 va ser Aina Surroca, vocal [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/47799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=47799"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/47799\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=47799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=47799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=47799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}